MG
UTHR icon

Michael Gelband’s United Therapeutics UTHR Stock Holding History

Michael Gelband’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745K Buy
+1,375
New +$774K ﹤0.01% 1141
2026
Q1 		– Sell
-18,102
Closed -$8.82M – 2128
2025
Q4 		$8.82M Sell
18,102
-16,117
-47% -$7.51M 0.07% 294
2025
Q3 		$14.3M Buy
+34,219
New +$11.5M 0.15% 129
2025
Q1 		– Sell
-5,383
Closed -$1.9M – 2026
2024
Q4 		$1.9M Buy
+5,383
New +$1.98M 0.01% 725
2023
Q3 		– Sell
-10,221
Closed -$2.26M – 2171
2023
Q2 		$2.26M Buy
10,221
+3,706
+57% +$821K 0.02% 761
2023
Q1 		$1.46M Sell
6,515
-117,992
-95% -$29.1M 0.01% 1007
2022
Q4 		$34.6M Buy
124,507
+95,310
+326% +$24.1M 0.5% 24
2022
Q3 		$6.11M Sell
29,197
-29,362
-50% -$6.56M 0.08% 341
2022
Q2 		$13.8M Buy
58,559
+32,860
+128% +$6.68M 0.17% 128
2022
Q1 		$4.61M Buy
25,699
+24,108
+1,515% +$4.59M 0.06% 416
2021
Q4 		$344K Sell
1,591
-10,474
-87% -$2.06M ﹤0.01% 1605
2021
Q3 		$2.23M Sell
12,065
-14,991
-55% -$2.95M 0.03% 686
2021
Q2 		$4.85M Buy
27,056
+3,974
+17% +$757K 0.05% 371
2021
Q1 		$3.86M Sell
23,082
-14,106
-38% -$2.35M 0.06% 352
2020
Q4 		$5.64M Buy
37,188
+34,020
+1,074% +$4.46M 0.06% 221
2020
Q3 		$320K Buy
+3,168
New +$348K 0.01% 1250
2020
Q2 		– Sell
-12,017
Closed -$1.14M – 2048
2020
Q1 		$1.14M Buy
12,017
+7,868
+190% +$748K 0.06% 278
2019
Q4 		$365K Sell
4,149
-38,504
-90% -$3.39M 0.01% 1035
2019
Q3 		$3.4M Buy
42,653
+36,171
+558% +$2.91M 0.12% 152
2019
Q2 		$506K Buy
+6,482
New +$606K 0.02% 466

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Michael Gelband's UTHR Position: Q2 2026 in Review

Michael Gelband opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,375 shares worth $745K. The stake represents ﹤0.01% of the portfolio and ranks #1141 among its holdings. This is a return to the name: Michael Gelband previously reported a position in UTHR as recently as Q4 2025.

Michael Gelband first reported a position in UTHR in Q2 2019 and has held it in 20 quarters since. The position peaked at $34.6M in Q4 2022. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Michael Gelband held 1,375 shares of United Therapeutics worth $745K as of Q2 2026.
  • United Therapeutics was a new Michael Gelband position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1141 holding.
  • Michael Gelband first reported a position in United Therapeutics in Q2 2019 and has held it in 20 quarters since.
  • Michael Gelband's United Therapeutics position peaked at $34.6M in Q4 2022.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.